Request FREE sample PDF
Pharmacy benefit management market
BALLOON INTRODUCER SYSTEM MARKET REPORT OVERVIEW
The global Balloon Introducer System Market size was USD 2400 million in 2022 and will touch USD 4171.9 million by 2029, exhibiting a CAGR of 8.2% during the forecast period.
A Balloon Introducer System can thus be described as a system that is applied in various minimal invasive procedures most especially in interventional cardiology and interventional radiology. These preferably include a balloon catheter and the introducer sheath.
COVID-19 Impact: Market Growth restrained by the Pandemic due to Supply Chain Disruptions
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
Problems such as pandemics and restrictions in several nations DIN impacted the processes of manufacturing. Managers highlighted the issue of lack of workforce, for many factories could not produce enough to meet the demand because of strikes that affected production sometimes for several days. Multinational entities shifted their focus and observed that integrating their operations on the basis of supply chain was not without its vices, primarily when there was upheaval; not only was there an issue regarding supply of material and elements.
LATEST TRENDS
"Growing Prevalence of Cardiovascular Diseases to Propel Market Growth"
Cardiovascular diseases are gradually rising and, moreover, greatly affect the balloon introducer system market because they are currently considered primary causes of morbidity and mortality at the global level. As a result of shifts in genealogy and other such factors, such as hypertension, diabetes, obesity, and the like, cardiovascular diseases are gradually on the incline, globally. This increased incidence of CVD actually creates pressure on its health care delivery systems to work on treatments that enhance the angioplasty’s effectiveness, minimize its invasiveness and reduce the risks for complications for this procedure such as balloon introducer systems. Since more patient have made a decision to undergo an intervention that entails the opening of blocked/narrowed arteries there is a high likelihood of deploying a balloon introducer system.
BALLOON INTRODUCER SYSTEM MARKET SEGMENTATION
By Type
Based on type the market can be categorized into Cutting and Scoring Balloon Introducer System, Drug-Coated Balloon Introducer System, Stent Graft Balloon Introducer System and Others.
- Cutting and Scoring Balloon Introducer System- Mounted with microtomes on the surface of the balloon. When the balloon is expanded, these blades cut small holes in the plaque; these incisions help in either eradicating the inflicted plaque or altering its existing structure.
- Drug-It is then coated with antiproliferative drug such as paclitaxel or sirolimus within which the more commonly used drug is paclitaxel. When the balloon is inflated the drug gets adsorbed on to the vessel wall.
- Stent Graft Balloon Introducer System- This specific kind of catheter is employed for the placement and, at the same time, the expansion of a stent graft in the area of an aneurism or a severed artery. It can therefore produce and sustain the mechanical environment of the vessel wall while at the same time carving out a new channel through which blood will circulate.
By Application
Based on application the market can be categorized into Coronary Artery Diseases, Peripheral Artery Diseases, Neurovascular Diseases and Others.
- Coronary Artery Diseases- The balloon introducer system is generally used to deliver a balloon catheter to exact the area of the atherosclerotic plaque in coronary arteries. The balloon part is inflated to squeeze the plaque against the interior walls of the artery making the circulation of blood to be enhanced.
- Peripheral Artery Diseases- Balloon introducer systems are employed to deal with the obstructions of peripheral arteries which include the limb arteries for example, the legs with intention to improve circulation of blood meaning that symptoms such as claudication are treated.
- Neurovascular Diseases- Balloons have been used in the placement of coils for aneurysms in the brain where after the coils had been placed, the balloons help to occlude the aneurysm, thereby avoiding rupture.
DRIVING FACTORS
"Minimally Invasive Procedures to Drive Market Advancement"
One of the key driving factors in the Balloon Introducer System market growth is the Minimally Invasive Procedures. Balloons introducers systems are well known since the different benefits that the minimally invasive interventional such as endovascular procedures present in front of the open surgery are the higher points for advancing this balloon introducer system market. These procedures include minimally invasive ones rare invasions, and early tissue healing, which has a lot of appeal to the patients and the practitioners in the health facilities. Balloon introducer system is widely used in various procedures of minimal invasive procedures including angioplasty used in the treatment of cardiovascular diseases the introducer system facilitates controlled release of balloon catheters in the circulatory system to widen constricted arteries. Lower complication rates, combined with shorter time in the hospital, and the ability to resume normal activities has improved the quality of the treatment, which boosts the use of minimally invasive procedures.
"Rising Demand for Ready-to-Eat Meals to Expand the Market"
This is due to the fact that improvement and enhancing healthcare expenditure boost the demand for innovation and improving medical technologies as well as infrastructure of the balloon introducer system market. Since more money is spent in the health sector coupled with increasing hospital and clinic expenditures, they are in a position to utilize modern technologies such as those that involve balloon introducer systems in different interventional procedures. These expenditures also enhance the ability of HLs to train and educate the personnel in the operation of these complex devices due to increased success rates in procedures, as well as better health outcomes to patients. Moreover, the increase in overall healthcare spending with a corresponding number of medical related services and insurance means can lead to adopting new therapeutic techniques for a wider range of population.
RESTRAINING FACTOR
"High Cost of Procedures and Devices Poses Potential Impediments to Market Growth "
Costs remains one of the major concerns when it comes to processing procedures and devices in Balloon Introducer System market which has consequence effects both on the healthcare providers’ side and the patients’ side. From the above discussions, it can be regarded that the hi-tech process and incorporation of superior materials in manufacturing balloon introducer system transfer the cost of production to hospitals and clinics. Such costs include not only the devices themselves but also equipment for ancillary use, constant maintenance costs, and training required for the healthcare personnel that will be using this innovation in their practice. To the healthcare providers, these systems represent a cost that may be hard to fund resulting in health care budget constraint especially in areas of low health care funding or areas of health human resource constraints.
BALLOON INTRODUCER SYSTEM MARKET REGIONAL INSIGHTS
"North America to Dominate the Market due to Advanced Healthcare Infrastructure"
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
North America has emerged as the most dominant region in the Balloon Introducer System market share due to a convergence of factors that propel its leadership in this dynamic industry. North America, specifically the USA, enjoys first-world provisions of health facilities with the focus on the incorporation of advanced technology in delivering medical services. The region also spends a large part of its Gross Domestic Product on health-care expenditure, thus making it easier for patient to access the kind of equipments like balloon introducer systems.
KEY INDUSTRY PLAYERS
"Key Players Transforming the Balloon Introducer System Landscape through Innovation and Global Strategy"
Major industry players are pivotal in shaping the Balloon Introducer System market, driving change through a dual strategy of continuous innovation and a well-thought-out global presence. By consistently introducing inventive solutions and staying at the forefront of technological progress, these key players redefine the industry's standards. Simultaneously, their expansive global reach enables effective market penetration, addressing diverse needs across borders. The seamless blend of groundbreaking innovation and a strategic international footprint positions these players as not only market leaders but also as architects of transformative shifts within the dynamic domain of Balloon Introducer System.
List of Market Players Profiled
- Terumo Corporation (Japan)
- OrbusNeich Medical (Hong Kong)
- MicroPort Scientific Corporation (China)
- B. Braun Melsungen AG (Germany)
- Abbott Laboratories (U.S.)
INDUSTRIAL DEVELOPMENT
2020: It is important to bring to the notice that Medtronic got the green signal from the US FDA for its IN. PACT arterial-venous fistula lacia lesions using drug-coated balloon (DCB).
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 2400 Million in 2022 |
Market Size Value By |
US$ 4171.9 Million by 2029 |
Growth Rate |
CAGR of 8.2% from 2022 to 2029 |
Forecast Period |
2022-2029 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the Balloon Introducer System market expected to touch by 2029?
The Balloon Introducer System market is expected to reach USD 4171.9 million by 2029.
-
What CAGR is the Balloon Introducer System Market expected to exhibit by 2029?
The Balloon Introducer System Market is expected to exhibit a CAGR of 8.2% by 2029.
-
Which are the driving factors of the Balloon Introducer System Market?
Minimally Invasive Procedures and Rising Demand for Ready-to-Eat Meals are some of the driving factors of the Balloon Introducer System market.
-
What are the key Balloon Introducer System Market segments?
The Balloon Introducer System market segmentation that you should be aware of, which includes, based on type the Balloon Introducer System market is classified as Cutting and Scoring Balloon Introducer System, Drug-Coated Balloon Introducer System, Stent Graft Balloon Introducer System and Others. Based on the application, the Balloon Introducer System market is classified as Coronary Artery Diseases, Peripheral Artery Diseases, Neurovascular Diseases and Others.